bcsls

BCSLS Calendar

Back to All Events

Telehealth: DIRECT ORAL ANTICOAGULANTS - A COMPREHENSIVE HISTORY AND CURRENT DEVELOPMENTS

Direct Oral Anticoagulant (DOAC) medications are a relatively new class of antithrombotic agents prescribed to patients who have displayed adverse reactions to traditional anticoagulant therapy.  Patients who have developed Heparin Induced Thrombocytopenia (HIT) antibodies due to prolonged heparin therapies have greatly benefitted from switching to DOAC’s for their antithrombotic regiments.  However, DOAC’s utilize new mechanisms of clot prevention which have the ability to cause new abnormalities in routine coagulation assays that bench technologists must be able to identify during the daily process of assay analysis.
 
This presentation will provide a comprehensive history of the development of DOAC medications, tips for identifying patients taking DOAC’s while performing coagulation assays, as well as an outline of the current advances and new, experimental therapies under investigation in this emerging field.

Earlier Event: June 2
BCSLS Board of Directors Meeting
Later Event: October 25
BCSLS Board of Directors Meeting